All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
The FDA has released a draft guidance for communications regarding on-label use of drugs and devices, which seems motivated in part by an interest in lending clarity to the off-label discussion.
